New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

This publication has 18 references indexed in Scilit:

• HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
  European Journal of Pharmaceutics and Biopharmaceutics, 2000
• Polymeric drugs based on conjugates of synthetic and natural macromolecules
  Journal of Controlled Release, 2000
• Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues
  Japanese Journal of Cancer Research, 1998
• Polymeric carriers of drugs for site-specific therapy
  Macromolecular Symposia, 1997
• Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin A
  Journal of Controlled Release, 1996
• Macromolecular prodrugs
  Progress in Polymer Science, 1995
• Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo
  Journal of Controlled Release, 1992
• Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycinImmunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro
  Biomaterials, 1989
• Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody
  Clinical Immunology and Immunopathology, 1988
• Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates
  Journal of Controlled Release, 1985